SAS User File for H68F17 Data This file contains information and sample SAS programs to create a permanent SAS dataset for users who want to use SAS in processing the MEPS data provided in this PUF release. There are two ways to create a permanent SAS dataset, using either the SAS transport data file (H68F17.SSP) or the ASCII data file (H68F17.DAT) supplied in this PUF release. Section A provides a sample SAS program for the first alternative, which is to convert the SAS transport data file to a regular SAS dataset using the SAS PROCedure: XCOPY. Section B provides a sample SAS program for the second alternative, which is to read data from the ASCII data file using a SAS DATA step with INFILE, INPUT, and LABEL statements. Section C explains format-related SAS statements that a user may optionally use when working with the SAS dataset. Examples of SAS programs (DATA step or PROC) are provided in all three sections, primarily for the benefit of inexperienced users. Section D contains complete SAS statements that must be used in the programs described in Sections B and C. INCLUDED BELOW ARE NOTES APPLICABLE TO USERS OF SAS VERSION 8 OR HIGHER. ****************************************************************************** The sample SAS programs provided in Sections A and B show how to create a permanent SAS dataset from the data files provided in this PUF release. A. A Sample SAS Program for Converting the SAS Transport File to a Permanent SAS Dataset The SAS PROCedure XCOPY will read a SAS transport file and convert the data to regular SAS format, storing the output in a permanent SAS dataset. This permanent SAS dataset can then be used for all future processing and analyses. Below is a sample SAS program that can be used to convert the SAS transport file to a permanent SAS dataset (in a Windows environment, with SAS V8 or higher). LIBNAME PUFLIB 'C:\MEPS\SASDATA'; FILENAME IN1 'C:\MEPS\DOWNLOAD\H68F17.SSP'; PROC XCOPY IN=IN1 OUT=PUFLIB IMPORT; RUN; SAS transport files, SAS data files, and SAS program files each should be stored in separate locations (directory names). Storing different types of SAS files in one location can cause errors with converting or retrieving data. Below are SAS statements to print a list of variables and a few sample records from the permanent SAS dataset: PROC CONTENTS DATA=PUFLIB.H68F17; TITLE 'List of Variables in MEPS H68F17 SAS Dataset'; RUN; PROC PRINT DATA=PUFLIB.H68F17 (OBS=20); TITLE 'First 20 Observations in MEPS H68F17 SAS Dataset'; RUN; The LIBNAME statement tells SAS the location (directory name) to store the permanent SAS dataset which is output by PROC XCOPY. The FILENAME statement tells SAS the location (complete directory and file name) of the input SAS transport data file. NOTES: 1) If you have an error reading a SAS data file you created, the problem may be a result of where you are storing and/or how you are retrieving the data. First check the data library for multiple releases of SAS files (e.g., V8 or higher with file extensions of '.SAS7BDAT' and V6 with file extensions of '.SD2') stored in the same location. a) You can avoid errors when reading these files by including the SAS release within the LIBNAME statement - e.g., LIBNAME PUFLIB V8 'C:\MEPS\SASDATA'; or b) Store SAS data files with different file extensions such as .SD2 and .SAS7BDAT, in separate folders (do not co-mingle V8 and V6 files in the same folder); or c) When importing transport files, output the SAS dataset to a different library than the one which contains the downloaded SAS transport file - e.g., LIBNAME PUFLIB 'C:\MEPS\SASDATA'; FILENAME IN1 'C:\MEPS\DOWNLOAD\Hxxx.SSP'; PROC XCOPY IN=IN1 OUT=PUBLIB IMPORT; RUN; 2) The names used in the LIBNAME and FILENAME statements shown above (i.e., PUFLIB, IN1) are arbitrary; they are only temporary aliases. 3) The directory and file names used in the LIBNAME and FILENAME statements shown above are Windows syntax and may need to be modified for other operating systems such as UNIX, MAC/OS, VMS, or OS/2. 4) H68F17 is the internal SAS dataset name (also the PC file name, without the extension) prior to the creation of the SAS transport data file. After running PROC XCOPY, the output SAS dataset assumes the same dataset name (or file name). Hence, in the example above, a file named H68F17.SAS7BDAT will be created under the C:\MEPS\SASDATA directory when PROC XCOPY runs successfully. 5) The SAS transport file H68F17.SSP was created from a SAS V9 data file, using PROC COPY. This file has been tested for use with SAS V8 or higher. This file may work with earlier versions of SAS, although it has not been tested with those versions. Users who are unable to use this SAS transport file should instead convert the ASCII data file H68F17.DAT to a SAS dataset as described in Section B. B. A Sample SAS Program for Converting the ASCII Data File to a Permanent SAS Dataset The complete SAS statements (INPUT and LABEL) included in Section D are intended to save time for those users wishing to create a permanent SAS dataset from the H68F17.DAT ASCII data file. These statements must be used in combination with other SAS statements to create the appropriate SAS program, as shown below. To use the statements provided in Section D to create a SAS program, you will need an ASCII text editor. If you are using an interactive form of SAS (Windows, UNIX, OS2, etc.), use the editor provided as part of the SAS software. Following is a sample SAS program that will convert the ASCII data file to SAS format: LIBNAME PUFLIB 'C:\MEPS\SASDATA'; FILENAME IN1 'C:\MEPS\DOWNLOAD\H68F17.DAT'; DATA PUFLIB.H68F17; INFILE IN1 LRECL=131; INPUT .....; * to user: insert the complete INPUT statement that is provided in Section D; LABEL .....; * to user: insert the complete LABEL statement that is provided in Section D; RUN; Here is an explanation of the SAS statements used in the program above. LIBNAME statement: This tells SAS the location (directory name) of the permanent SAS dataset. FILENAME statement: This tells SAS the location of the input ASCII data file. DATA statement: This signifies the beginning of a SAS DATA step and specifies the output SAS dataset, referencing the LIBNAME entry (PUFLIB) and assigning an internal SAS dataset name (H68F17). In the example, after the successful completion of the DATA step, a PC file named H68F17.SAS7BDAT would have been created in the C:\MEPS\SASDATA directory. INFILE statement: This tells SAS the location (directory and file name) of the input ASCII data file. Also provided is the logical record length (131 bytes), with the default of RECFM=V implied when this parameter is omitted. LRECL and RECFM are optional parameters in the INFILE statement. With regard to these options, please note the following: the ASCII data file H68F17.DAT contains a 2-byte carriage return/line feed at the end of each record. When converting to a PC-SAS file, the LRECL option should be used to specify the record length to avoid use of a default record length by PC-SAS. If the RECFM=V option is used, the LRECL option must be specified as the logical record length (e.g., 131 for H68F17.DAT). If RECFM=F is used, then the LRECL value must be specified as the logical record length plus 2 (133 for H68F17.DAT). Note that if the RECFM option is omitted, then the default option of RECFM=V is automatically used, and LRECL should be specified as the logical record (131 for H68F17.DAT). INPUT statement: This specifies the input record layout, giving names and the beginning and ending column positions for data items (which become SAS variables) in the ASCII data file (H68F17.DAT). Variable type (numeric or character) is also defined via the INPUT statement. LABEL statement: This associates descriptive names with the SAS variables. RUN statement: This tells SAS to execute all commands up to this point. See Section A.1 above for tips on retrieving and storing the permanent SAS data files. C. Optional Format-related SAS Statements If a user wants to use formats for the SAS variables, a SAS format library must first be created. Below is a SAS program that will accomplish this: LIBNAME PUFLIB 'C:\MEPS\SASDATA'; PROC FORMAT LIBRARY=PUFLIB; VALUE .....; * to user: insert the complete set of VALUE statements found in Section D; VALUE .....; .......... ; RUN; Below is an example of how to use the SAS formats defined by the PROC FORMAT procedure: LIBNAME PUFLIB 'C:\MEPS\SASDATA'; OPTIONS FMTSEARCH=(PUFLIB); PROC FREQ DATA=PUFLIB.H68F17; TABLES .... / LIST MISSING; FORMAT varnam1 fmtnam1. Varnam2 fmtnam2. .... ; * to user: substitute varnam1 and fmtnam1 with actual variable names and format names; * Insert the FORMAT statement provided in Section D, if you are using all the variables in the TABLES statement; TITLE 'Frequency Distributions ....'; RUN; Here is an explanation of the SAS statements used above. LIBNAME statement: This tells SAS the location (directory name) of the SAS format library. Please note that SAS datasets (file name extension is 'SAS7BDAT' for SAS V8 or higher and 'SD2' for SAS V6) and format libraries (file name extension is 'SAS7BCAT' for SAS V8 or higher and 'SC2' for SAS V6) can be stored under the same directory. OPTIONS FMTSEARCH=...: This specifies the SAS format library. PROC FORMAT statement: This identifies the SAS procedure that will make SAS formats according to VALUE statements. Formats will be stored in a file named FORMATS.SAS7BCAT. Please note that the option 'LIBRARY=...' can be omitted if the user does not want to create a permanent SAS format library. When simply 'PROC FORMAT;' is used, the formats are defined only for the duration of the batch SAS program or an interactive SAS session. VALUE statement: This gives a) names to formats; and b) descriptive labels for individual values, or range of values. The format names can then be invoked using a FORMAT statement if desired. PROC FREQ statement: This identifies the SAS procedure that generates frequency distributions of variables specified in the TABLES statement, formatted if a FORMAT statement is used. The input SAS dataset is specified in the 'DATA=' option. FORMAT statement: This associates existing formats with variables. When using this statement, the formats must have already been created with a PROC FORMAT procedure. RUN statement: This tells SAS to execute all commands up to this point. NOTES: 1) Use of formats is entirely optional, and depends on the types of analyses that you are doing. It is recommended that you create and use them as appropriate. 2) The names used in the LIBNAME and FILENAME statements shown above (i.e., PUFLIB, IN1) are arbitrary; they are only temporary aliases. 3) You only create the permanent SAS dataset once. Additional analyses can be run using this permanent dataset. 4) The file and directory specifications in the LIBNAME and FILENAME statements are Windows syntax and may need to be modified for other operating systems such as UNIX, MAC/OS, VMS, or OS/2. D. SAS Statements This section contains SAS INPUT, LABEL, FORMAT, and VALUE statements for use in converting the ASCII H68F17.DAT file into a SAS dataset, and for creating SAS formats. * INPUT STATEMENTS; INFILE IN LRECL=131; INPUT @1 DUPERSID $8.0 @9 RXRECIDX $15.0 @24 RXDRGNAM $60.0 @84 PREGCAT $2.0 @86 TC1 3.0 @89 TC1S1 3.0 @92 TC1S1_1 3.0 @95 TC1S1_2 3.0 @98 TC1S2 3.0 @101 TC1S2_1 3.0 @104 TC1S3 2.0 @106 TC1S3_1 2.0 @108 TC2 3.0 @111 TC2S1 3.0 @114 TC2S1_1 3.0 @117 TC2S1_2 3.0 @120 TC2S2 3.0 @123 TC3 3.0 @126 TC3S1 3.0 @129 TC3S1_1 3.0 ; * FORMAT STATEMENTS; FORMAT DUPERSID $DUPERSI. RXRECIDX $RXRECIX. RXDRGNAM $DRGNAM1F. PREGCAT $PREGCAT. TC1 TCNAME. TC1S1 TCNAME. TC1S1_1 TCNAME. TC1S1_2 TCNAME. TC1S2 TCNAME. TC1S2_1 TCNAME. TC1S3 TCNAME. TC1S3_1 TCNAME. TC2 TCNAME. TC2S1 TCNAME. TC2S1_1 TCNAME. TC2S1_2 TCNAME. TC2S2 TCNAME. TC3 TCNAME. TC3S1 TCNAME. TC3S1_1 TCNAME. ; * LABEL STATEMENTS; LABEL DUPERSID='ENCRYPTED PERSON ID (DUID + PID)' RXRECIDX='UNIQUE RX/PRESCRIBED MEDICINE IDENTIFIER' RXDRGNAM='MULTUM MEDICINE NAME (IMPUTED)' PREGCAT ='MULTUM PREGNANCY CATEGORY' TC1 ='MULTUM THERAPEUTIC CLASS #1' TC1S1 ='MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC1' TC1S1_1 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC1S1' TC1S1_2 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC1S1' TC1S2 ='MULTUM THERAPEUTIC SUB-CLASS #2 FOR TC1' TC1S2_1 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC1S2' TC1S3 ='MULTUM THERAPEUTIC SUB-CLASS #3 FOR TC1' TC1S3_1 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC1S3' TC2 ='MULTUM THERAPEUTIC CLASS #2' TC2S1 ='MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC2' TC2S1_1 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC2S1' TC2S1_2 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC2S1' TC2S2 ='MULTUM THERAPEUTIC SUB-CLASS #2 FOR TC2' TC3 ='MULTUM THERAPEUTIC CLASS #3' TC3S1 ='MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC3' TC3S1_1 ='MULTUM THERAPEUT SUB-SUB-CLASS FOR TC3S1' ; * VALUE STATEMENTS; VALUE $DRGNAM1F '-7' = '-7 REFUSED' '-8' = '-8 DK' '-9' = '-9 NOT ASCERTAINED' OTHER = 'A-ZZZZZZZZZZ' ; VALUE $DUPERSI OTHER = 'VALID ID' ; VALUE $PREGCAT '-1' = '-1 INAPPLICABLE' '-9' = '-9 NOT ASCERTAINED' 'A' = 'A CONTROLLED STUDIES SHOW NO RISK' 'B' = 'B NO EVIDENCE OF RISK IN HUMANS' 'C' = 'C RISK CANNOT BE RULED OUT' 'D' = 'D POSITIVE EVIDENCE OF RISK' 'N' = 'N FDA HAS NOT CLASSIFIED THE RX' 'X' = 'X CONTRAINDICATED IN PREGNANCY' ; VALUE $RXRECIX OTHER = 'VALID ID' ; VALUE TCNAME -9 = '-9 NOT ASCERTAINED' -1 = '-1 INAPPLICABLE' 1 = '1 ANTI-INFECTIVES' 2 = '2 AMEBICIDES' 3 = '3 ANTHELMINTICS' 4 = '4 ANTIFUNGALS' 5 = '5 ANTIMALARIAL AGENTS' 6 = '6 ANTITUBERCULOSIS AGENTS' 7 = '7 ANTIVIRAL AGENTS' 8 = '8 CARBAPENEMS' 9 = '9 CEPHALOSPORINS' 10 = '10 LEPROSTATICS' 11 = '11 MACROLIDE DERIVATIVES' 12 = '12 MISCELLANEOUS ANTIBIOTICS' 13 = '13 PENICILLINS' 14 = '14 QUINOLONES' 15 = '15 SULFONAMIDES' 16 = '16 TETRACYCLINES' 17 = '17 URINARY ANTI-INFECTIVES' 18 = '18 AMINOGLYCOSIDES' 19 = '19 ANTIHYPERLIPIDEMIC AGENTS' 20 = '20 ANTINEOPLASTICS' 21 = '21 ALKYLATING AGENTS' 22 = '22 ANTINEOPLASTIC ANTIBIOTICS' 23 = '23 ANTIMETABOLITES' 24 = '24 ANTINEOPLASTIC HORMONES' 25 = '25 MISCELLANEOUS ANTINEOPLASTICS' 26 = '26 MITOTIC INHIBITORS' 27 = '27 RADIOPHARMACEUTICALS' 28 = '28 BIOLOGICALS' 30 = '30 ANTITOXINS AND ANTIVENINS' 31 = '31 BACTERIAL VACCINES' 32 = '32 COLONY STIMULATING FACTORS' 33 = '33 IMMUNE GLOBULINS' 34 = '34 IN VIVO DIAGNOSTIC BIOLOGICALS' 36 = '36 ERYTHROPOIESIS-STIMULATING AGENTS' 37 = '37 TOXOIDS' 38 = '38 VIRAL VACCINES' 39 = '39 MISCELLANEOUS BIOLOGICALS' 40 = '40 CARDIOVASCULAR AGENTS' 41 = '41 AGENTS FOR HYPERTENSIVE EMERGENCIES' 42 = '42 ANGIOTENSIN CONVERTING ENZYME INHIBITORS' 43 = '43 ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING' 44 = '44 ANTIADRENERGIC AGENTS, CENTRALLY ACTING' 45 = '45 ANTIANGINAL AGENTS' 46 = '46 ANTIARRHYTHMIC AGENTS' 47 = '47 BETA-ADRENERGIC BLOCKING AGENTS' 48 = '48 CALCIUM CHANNEL BLOCKING AGENTS' 49 = '49 DIURETICS' 50 = '50 INOTROPIC AGENTS' 51 = '51 MISCELLANEOUS CARDIOVASCULAR AGENTS' 52 = '52 PERIPHERAL VASODILATORS' 53 = '53 VASODILATORS' 54 = '54 VASOPRESSORS' 55 = '55 ANTIHYPERTENSIVE COMBINATIONS' 56 = '56 ANGIOTENSIN II INHIBITORS' 57 = '57 CENTRAL NERVOUS SYSTEM AGENTS' 58 = '58 ANALGESICS' 59 = '59 MISCELLANEOUS ANALGESICS' 60 = '60 NARCOTIC ANALGESICS' 61 = '61 NONSTEROIDAL ANTI-INFLAMMATORY AGENTS' 62 = '62 SALICYLATES' 63 = '63 ANALGESIC COMBINATIONS' 64 = '64 ANTICONVULSANTS' 65 = '65 ANTIEMETIC/ANTIVERTIGO AGENTS' 66 = '66 ANTIPARKINSON AGENTS' 67 = '67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS' 68 = '68 BARBITURATES' 69 = '69 BENZODIAZEPINES' 70 = '70 MISC ANXIOLYTICS, SEDATIVES AND HYPNOTICS' 71 = '71 CNS STIMULANTS' 72 = '72 GENERAL ANESTHETICS' 73 = '73 MUSCLE RELAXANTS' 74 = '74 NEUROMUSCULAR BLOCKING AGENTS' 76 = '76 MISCELLANEOUS ANTIDEPRESSANTS' 77 = '77 MISCELLANEOUS ANTIPSYCHOTIC AGENTS' 79 = '79 PSYCHOTHERAPEUTIC COMBINATIONS' 80 = '80 MISC CENTRAL NERVOUS SYSTEM AGENTS' 81 = '81 COAGULATION MODIFIERS' 82 = '82 ANTICOAGULANTS' 83 = '83 ANTIPLATELET AGENTS' 84 = '84 HEPARIN ANTAGONISTS' 85 = '85 MISCELLANEOUS COAGULATION MODIFIERS' 86 = '86 THROMBOLYTICS' 87 = '87 GASTROINTESTINAL AGENTS' 88 = '88 ANTACIDS' 89 = '89 ANTICHOLINERGICS/ANTISPASMODICS' 90 = '90 ANTIDIARRHEALS' 91 = '91 DIGESTIVE ENZYMES' 92 = '92 GALLSTONE SOLUBILIZING AGENTS' 93 = '93 GI STIMULANTS' 94 = '94 H2 ANTAGONISTS' 95 = '95 LAXATIVES' 96 = '96 MISCELLANEOUS GI AGENTS' 97 = '97 HORMONES/HORMONE MODIFIERS' 98 = '98 ADRENAL CORTICAL STEROIDS' 99 = '99 ANTIDIABETIC AGENTS' 100 = '100 MISCELLANEOUS HORMONES' 101 = '101 SEX HORMONES' 102 = '102 CONTRACEPTIVES' 103 = '103 THYROID HORMONES' 104 = '104 IMMUNOSUPPRESSIVE AGENTS' 105 = '105 MISCELLANEOUS AGENTS' 106 = '106 ANTIDOTES' 107 = '107 CHELATING AGENTS' 108 = '108 CHOLINERGIC MUSCLE STIMULANTS' 109 = '109 LOCAL INJECTABLE ANESTHETICS' 110 = '110 MISCELLANEOUS UNCATEGORIZED AGENTS' 111 = '111 PSORALENS' 112 = '112 RADIOCONTRAST AGENTS' 113 = '113 GENITOURINARY TRACT AGENTS' 114 = '114 ILLICIT (STREET) DRUGS' 115 = '115 NUTRITIONAL PRODUCTS' 116 = '116 IRON PRODUCTS' 117 = '117 MINERALS AND ELECTROLYTES' 118 = '118 ORAL NUTRITIONAL SUPPLEMENTS' 119 = '119 VITAMINS' 120 = '120 VITAMIN AND MINERAL COMBINATIONS' 121 = '121 INTRAVENOUS NUTRITIONAL PRODUCTS' 122 = '122 RESPIRATORY AGENTS' 123 = '123 ANTIHISTAMINES' 124 = '124 ANTITUSSIVES' 125 = '125 BRONCHODILATORS' 126 = '126 METHYLXANTHINES' 127 = '127 DECONGESTANTS' 128 = '128 EXPECTORANTS' 129 = '129 MISCELLANEOUS RESPIRATORY AGENTS' 130 = '130 RESPIRATORY INHALANT PRODUCTS' 131 = '131 ANTIASTHMATIC COMBINATIONS' 132 = '132 UPPER RESPIRATORY COMBINATIONS' 133 = '133 TOPICAL AGENTS' 134 = '134 ANORECTAL PREPARATIONS' 135 = '135 ANTISEPTIC AND GERMICIDES' 136 = '136 DERMATOLOGICAL AGENTS' 137 = '137 TOPICAL ANTI-INFECTIVES' 138 = '138 TOPICAL STEROIDS' 139 = '139 TOPICAL ANESTHETICS' 140 = '140 MISCELLANEOUS TOPICAL AGENTS' 141 = '141 TOPICAL STEROIDS WITH ANTI-INFECTIVES' 143 = '143 TOPICAL ACNE AGENTS' 144 = '144 TOPICAL ANTIPSORIATICS' 146 = '146 MOUTH AND THROAT PRODUCTS' 147 = '147 OPHTHALMIC PREPARATIONS' 148 = '148 OTIC PREPARATIONS' 149 = '149 SPERMICIDES' 150 = '150 STERILE IRRIGATING SOLUTIONS' 151 = '151 VAGINAL PREPARATIONS' 153 = '153 PLASMA EXPANDERS' 154 = '154 LOOP DIURETICS' 155 = '155 POTASSIUM-SPARING DIURETICS' 156 = '156 THIAZIDE DIURETICS' 157 = '157 CARBONIC ANHYDRASE INHIBITORS' 158 = '158 MISCELLANEOUS DIURETICS' 159 = '159 FIRST GENERATION CEPHALOSPORINS' 160 = '160 SECOND GENERATION CEPHALOSPORINS' 161 = '161 THIRD GENERATION CEPHALOSPORINS' 162 = '162 FOURTH GENERATION CEPHALOSPORINS' 163 = '163 OPHTHALMIC ANTI-INFECTIVES' 164 = '164 OPHTHALMIC GLAUCOMA AGENTS' 165 = '165 OPHTHALMIC STEROIDS' 166 = '166 OPHTHALMIC STEROIDS WITH ANTI-INFECTIVES' 167 = '167 OPHTHALMIC ANTI-INFLAMMATORY AGENTS' 168 = '168 OPHTHALMIC LUBRICANTS AND IRRIGATIONS' 169 = '169 MISCELLANEOUS OPHTHALMIC AGENTS' 170 = '170 OTIC ANTI-INFECTIVES' 171 = '171 OTIC STEROIDS WITH ANTI-INFECTIVES' 172 = '172 MISCELLANEOUS OTIC AGENTS' 173 = '173 HMG-COA REDUCTASE INHIBITORS' 174 = '174 MISCELLANEOUS ANTIHYPERLIPIDEMIC AGENTS' 175 = '175 PROTEASE INHIBITORS' 176 = '176 NRTIS' 177 = '177 MISCELLANEOUS ANTIVIRALS' 178 = '178 SKELETAL MUSCLE RELAXANTS' 179 = '179 SKELETAL MUSCLE RELAXANT COMBINATIONS' 180 = '180 ADRENERGIC BRONCHODILATORS' 181 = '181 BRONCHODILATOR COMBINATIONS' 182 = '182 ANDROGENS AND ANABOLIC STEROIDS' 183 = '183 ESTROGENS' 184 = '184 GONADOTROPINS' 185 = '185 PROGESTINS' 186 = '186 SEX HORMONE COMBINATIONS' 187 = '187 MISCELLANEOUS SEX HORMONES' 191 = '191 NARCOTIC ANALGESIC COMBINATIONS' 192 = '192 ANTIRHEUMATICS' 193 = '193 ANTIMIGRAINE AGENTS' 194 = '194 ANTIGOUT AGENTS' 195 = '195 5HT3 RECEPTOR ANTAGONISTS' 196 = '196 PHENOTHIAZINE ANTIEMETICS' 197 = '197 ANTICHOLINERGIC ANTIEMETICS' 198 = '198 MISCELLANEOUS ANTIEMETICS' 199 = '199 HYDANTOIN ANTICONVULSANTS' 200 = '200 SUCCINIMIDE ANTICONVULSANTS' 201 = '201 BARBITURATE ANTICONVULSANTS' 202 = '202 OXAZOLIDINEDIONE ANTICONVULSANTS' 203 = '203 BENZODIAZEPINE ANTICONVULSANTS' 204 = '204 MISCELLANEOUS ANTICONVULSANTS' 205 = '205 ANTICHOLINERGIC ANTIPARKINSON AGENTS' 206 = '206 MISCELLANEOUS ANTIPARKINSON AGENTS' 208 = '208 SSRI ANTIDEPRESSANTS' 209 = '209 TRICYCLIC ANTIDEPRESSANTS' 210 = '210 PHENOTHIAZINE ANTIPSYCHOTICS' 211 = '211 PLATELET AGGREGATION INHIBITORS' 212 = '212 GLYCOPROTEIN PLATELET INHIBITORS' 213 = '213 SULFONYLUREAS' 214 = '214 BIGUANIDES' 215 = '215 INSULIN' 216 = '216 ALPHA-GLUCOSIDASE INHIBITORS' 217 = '217 BISPHOSPHONATES' 218 = '218 ALTERNATIVE MEDICINES' 219 = '219 NUTRACEUTICAL PRODUCTS' 220 = '220 HERBAL PRODUCTS' 222 = '222 PENICILLINASE RESISTANT PENICILLINS' 223 = '223 ANTIPSEUDOMONAL PENICILLINS' 224 = '224 AMINOPENICILLINS' 225 = '225 BETA-LACTAMASE INHIBITORS' 226 = '226 NATURAL PENICILLINS' 227 = '227 NNRTIS' 228 = '228 ADAMANTANE ANTIVIRALS' 229 = '229 PURINE NUCLEOSIDES' 230 = '230 AMINOSALICYLATES' 231 = '231 THIOCARBAMIDE DERIVATIVES' 232 = '232 RIFAMYCIN DERIVATIVES' 233 = '233 STREPTOMYCES DERIVATIVES' 234 = '234 MISCELLANEOUS ANTITUBERCULOSIS AGENTS' 235 = '235 POLYENES' 236 = '236 AZOLE ANTIFUNGALS' 237 = '237 MISCELLANEOUS ANTIFUNGALS' 238 = '238 ANTIMALARIAL QUINOLINES' 239 = '239 MISCELLANEOUS ANTIMALARIALS' 240 = '240 LINCOMYCIN DERIVATIVES' 241 = '241 FIBRIC ACID DERIVATIVES' 242 = '242 PSYCHOTHERAPEUTIC AGENTS' 243 = '243 LEUKOTRIENE MODIFIERS' 244 = '244 NASAL LUBRICANTS AND IRRIGATIONS' 245 = '245 NASAL STEROIDS' 246 = '246 NASAL ANTIHISTAMINES AND DECONGESTANTS' 247 = '247 NASAL PREPARATIONS' 248 = '248 TOPICAL EMOLLIENTS' 249 = '249 ANTIDEPRESSANTS' 250 = '250 MONOAMINE OXIDASE INHIBITORS' 251 = '251 ANTIPSYCHOTICS' 252 = '252 BILE ACID SEQUESTRANTS' 253 = '253 ANOREXIANTS' 254 = '254 IMMUNOLOGIC AGENTS' 256 = '256 INTERFERONS' 257 = '257 IMMUNOSUPPRESSIVE MONOCLONAL ANTIBODIES' 261 = '261 HEPARINS' 262 = '262 COUMARINS AND INDANDIONES' 263 = '263 IMPOTENCE AGENTS' 264 = '264 URINARY ANTISPASMODICS' 265 = '265 URINARY PH MODIFIERS' 266 = '266 MISCELLANEOUS GENITOURINARY TRACT AGENTS' 267 = '267 OPHTHALMIC ANTIHISTAMINES, DECONGESTANTS' 268 = '268 VAGINAL ANTI-INFECTIVES' 269 = '269 MISCELLANEOUS VAGINAL AGENTS' 270 = '270 ANTIPSORIATICS' 271 = '271 THIAZOLIDINEDIONES' 272 = '272 PROTON PUMP INHIBITORS' 273 = '273 LUNG SURFACTANTS' 274 = '274 CARDIOSELECTIVE BETA BLOCKERS' 275 = '275 NON-CARDIOSELECTIVE BETA BLOCKERS' 276 = '276 DOPAMINERGIC ANTIPARKINSONISM AGENTS' 277 = '277 5-AMINOSALICYLATES' 278 = '278 COX-2 INHIBITORS' 279 = '279 GONADOTROPIN-RELEASING HORMONE AND ANALOGS' 280 = '280 THIOXANTHENES' 281 = '281 NEURAMINIDASE INHIBITORS' 282 = '282 MEGLITINIDES' 283 = '283 THROMBIN INHIBITORS' 284 = '284 VISCOSUPPLEMENTATION AGENTS' 285 = '285 FACTOR XA INHIBITORS' 286 = '286 MYDRIATICS' 287 = '287 OPHTHALMIC ANESTHETICS' 288 = '288 5-ALPHA-REDUCTASE INHIBITORS' 289 = '289 ANTIHYPERURICEMIC AGENTS' 290 = '290 TOPICAL ANTIBIOTICS' 291 = '291 TOPICAL ANTIVIRALS' 292 = '292 TOPICAL ANTIFUNGALS' 293 = '293 GLUCOSE ELEVATING AGENTS' 295 = '295 GROWTH HORMONES' 296 = '296 INHALED CORTICOSTEROIDS' 297 = '297 MUCOLYTICS' 298 = '298 MAST CELL STABILIZERS' 299 = '299 ANTICHOLINERGIC BRONCHODILATORS' 300 = '300 CORTICOTROPIN' 301 = '301 GLUCOCORTICOIDS' 302 = '302 MINERALOCORTICOIDS' 303 = '303 AGENTS FOR PULMONARY HYPERTENSION' 304 = '304 MACROLIDES' 305 = '305 KETOLIDES' 306 = '306 PHENYLPIPERAZINE ANTIDEPRESSANTS' 307 = '307 TETRACYCLIC ANTIDEPRESSANTS' 308 = '308 SSNRI ANTIDEPRESSANTS' 309 = '309 MISCELLANEOUS ANTIDIABETIC AGENTS' 310 = '310 ECHINOCANDINS' 311 = '311 DIBENZAZEPINE ANTICONVULSANTS' 312 = '312 CHOLINERGIC AGONISTS' 313 = '313 CHOLINESTERASE INHIBITORS' 314 = '314 ANTIDIABETIC COMBINATIONS' 315 = '315 GLYCYLCYCLINES' 316 = '316 CHOLESTEROL ABSORPTION INHIBITORS' 317 = '317 ANTIHYPERLIPIDEMIC COMBINATIONS' 318 = '318 INSULIN-LIKE GROWTH FACTOR' 319 = '319 VASOPRESSIN ANTAGONISTS' 320 = '320 SMOKING CESSATION AGENTS' 321 = '321 OPHTHALMIC DIAGNOSTIC AGENTS' 322 = '322 OPHTHALMIC SURGICAL AGENTS' 323 = '323 ANTINEOPLASTIC MONOCLONAL ANTIBODIES' 324 = '324 ANTINEOPLASTIC INTERFERONS' 325 = '325 SCLEROSING AGENTS' 327 = '327 ANTIVIRAL COMBINATIONS' 328 = '328 ANTIMALARIAL COMBINATIONS' 329 = '329 ANTITUBERCULOSIS COMBINATIONS' 330 = '330 ANTIVIRAL INTERFERONS' 331 = '331 RADIOLOGIC AGENTS' 332 = '332 RADIOLOGIC ADJUNCTS' 333 = '333 MISCELLANEOUS IODINATED CONTRAST MEDIA' 334 = '334 LYMPHATIC STAINING AGENTS' 335 = '335 MAGNETIC RESONANCE IMAGING CONTRAST MEDIA' 336 = '336 NON-IODINATED CONTRAST MEDIA' 337 = '337 ULTRASOUND CONTRAST MEDIA' 338 = '338 DIAGNOSTIC RADIOPHARMACEUTICALS' 339 = '339 THERAPEUTIC RADIOPHARMACEUTICALS' 340 = '340 ALDOSTERONE RECEPTOR ANTAGONISTS' 341 = '341 ATYPICAL ANTIPSYCHOTICS' 342 = '342 RENIN INHIBITORS' 343 = '343 TYROSINE KINASE INHIBITORS' 344 = '344 NASAL ANTI-INFECTIVES' 345 = '345 FATTY ACID DERIVATIVE ANTICONVULSANTS' 346 = '346 GAMMA-AMINOBUTYRIC ACID REUPTAKE INHIBITORS' 347 = '347 GAMMA-AMINOBUTYRIC ACID ANALOGS' 348 = '348 TRIAZINE ANTICONVULSANTS' 349 = '349 CARBAMATE ANTICONVULSANTS' 350 = '350 PYRROLIDINE ANTICONVULSANTS' 351 = '351 CARBONIC ANHYDRASE INHIBITOR ANTICONVULSANTS' 352 = '352 UREA ANTICONVULSANTS' 353 = '353 ANTI-ANGIOGENIC OPHTHALMIC AGENTS' 354 = '354 H. PYLORI ERADICATION AGENTS' 355 = '355 FUNCTIONAL BOWEL DISORDER AGENTS' 356 = '356 SEROTONINERGIC NEUROENTERIC MODULATORS' 357 = '357 GROWTH HORMONE RECEPTOR BLOCKERS' 358 = '358 METABOLIC AGENTS' 359 = '359 PERIPHERALLY ACTING ANTIOBESITY AGENTS' 360 = '360 LYSOSOMAL ENZYMES' 361 = '361 MISCELLANEOUS METABOLIC AGENTS' 362 = '362 CHLORIDE CHANNEL ACTIVATORS' 363 = '363 PROBIOTICS' 364 = '364 ANTIVIRAL CHEMOKINE RECEPTOR ANTAGONIST' 365 = '365 MEDICAL GAS' 366 = '366 INTEGRASE STRAND TRANSFER INHIBITOR' 368 = '368 NON-IONIC IODINATED CONTRAST MEDIA' 369 = '369 IONIC IODINATED CONTRAST MEDIA' 370 = '370 OTIC STEROIDS' 371 = '371 DIPEPTIDYL PEPTIDASE 4 INHIBITORS' 372 = '372 AMYLIN ANALOGS' 373 = '373 INCRETIN MIMETICS' 374 = '374 CARDIAC STRESSING AGENTS' 375 = '375 PERIPHERAL OPIOID RECEPTOR ANTAGONISTS' 376 = '376 RADIOLOGIC CONJUGATING AGENTS' 377 = '377 PROLACTIN INHIBITORS' 378 = '378 DRUGS USED IN ALCOHOL DEPENDENCE' 379 = '379 NEXT GENERATION CEPHALOSPORINS' 380 = '380 TOPICAL DEBRIDING AGENTS' 381 = '381 TOPICAL DEPIGMENTING AGENTS' 382 = '382 TOPICAL ANTIHISTAMINES' 383 = '383 ANTINEOPLASTIC DETOXIFYING AGENTS' 384 = '384 PLATELET-STIMULATING AGENTS' 385 = '385 GROUP I ANTIARRHYTHMICS' 386 = '386 GROUP II ANTIARRHYTHMICS' 387 = '387 GROUP III ANTIARRHYTHMICS' 388 = '388 GROUP IV ANTIARRHYTHMICS' 389 = '389 GROUP V ANTIARRHYTHMICS' 390 = '390 HEMATOPOIETIC STEM CELL MOBILIZER' 391 = '391 MTOR KINASE INHIBITORS' 392 = '392 OTIC ANESTHETICS' 393 = '393 CERUMENOLYTICS' 394 = '394 TOPICAL ASTRINGENTS' 395 = '395 TOPICAL KERATOLYTICS' 396 = '396 PROSTAGLANDIN D2 ANTAGONISTS' 397 = '397 MULTIKINASE INHIBITORS' 398 = '398 BCR-ABL TYROSINE KINASE INHIBITORS' 399 = '399 CD52 MONOCLONAL ANTIBODIES' 400 = '400 CD33 MONOCLONAL ANTIBODIES' 401 = '401 CD20 MONOCLONAL ANTIBODIES' 402 = '402 VEGF/VEGFR INHIBITORS' 403 = '403 MTOR INHIBITORS' 404 = '404 EGFR INHIBITORS' 405 = '405 HER2 INHIBITORS' 406 = '406 GLYCOPEPTIDE ANTIBIOTICS' 407 = '407 INHALED ANTI-INFECTIVES' 408 = '408 HISTONE DEACETYLASE INHIBITORS' 409 = '409 BONE RESORPTION INHIBITORS' 410 = '410 ADRENAL CORTICOSTEROID INHIBITORS' 411 = '411 CALCITONIN' 412 = '412 UTEROTONIC AGENTS' 413 = '413 ANTIGONADOTROPIC AGENTS' 414 = '414 ANTIDIURETIC HORMONES' 415 = '415 MISCELLANEOUS BONE RESORPTION INHIBITORS' 416 = '416 SOMATOSTATIN AND SOMATOSTATIN ANALOGS' 417 = '417 SELECTIVE ESTROGEN RECEPTOR MODULATORS' 418 = '418 PARATHYROID HORMONE AND ANALOGS' 419 = '419 GONADOTROPIN-RELEASING HORMONE ANTAGONISTS' 420 = '420 ANTIANDROGENS' 422 = '422 ANTITHYROID AGENTS' 423 = '423 AROMATASE INHIBITORS' 424 = '424 ESTROGEN RECEPTOR ANTAGONISTS' 426 = '426 SYNTHETIC OVULATION STIMULANTS' 427 = '427 TOCOLYTIC AGENTS' 428 = '428 PROGESTERONE RECEPTOR MODULATORS' 429 = '429 TRIFUNCTIONAL MONOCLONAL ANTIBODIES' 430 = '430 ANTICHOLINERGIC CHRONOTROPIC AGENTS' 431 = '431 ANTI-CTLA-4 MONOCLONAL ANTIBODIES' 432 = '432 VACCINE COMBINATIONS' 433 = '433 CATECHOLAMINES' 435 = '435 SELECTIVE PHOSPHODIESTERASE-4 INHIBITORS' 437 = '437 IMMUNOSTIMULANTS' 438 = '438 INTERLEUKINS' 439 = '439 OTHER IMMUNOSTIMULANTS' 440 = '440 THERAPEUTIC VACCINES' 441 = '441 CALCINEURIN INHIBITORS' 442 = '442 TNF ALFA INHIBITORS' 443 = '443 INTERLEUKIN INHIBITORS' 444 = '444 SELECTIVE IMMUNOSUPPRESSANTS' 445 = '445 OTHER IMMUNOSUPPRESSANTS' 446 = '446 NEURONAL POTASSIUM CHANNEL OPENERS' 447 = '447 CD30 MONOCLONAL ANTIBODIES' 448 = '448 TOPICAL NON-STEROIDAL ANTI-INFLAMMATORIES' 449 = '449 HEDGEHOG PATHWAY INHIBITORS' 450 = '450 TOPICAL ANTINEOPLASTICS' 451 = '451 TOPICAL PHOTOCHEMOTHERAPEUTICS' 452 = '452 CFTR POTENTIATORS' 453 = '453 TOPICAL RUBEFACIENT' 454 = '454 PROTEASOME INHIBITORS' 455 = '455 GUANYLATE CYCLASE-C AGONISTS' 456 = '456 AMPA RECEPTOR ANTAGONISTS' 457 = '457 HYDRAZIDE DERIVATIVES' 458 = '458 SGLT-2 INHIBITORS' 459 = '459 UREA CYCLE DISORDER AGENTS' 460 = '460 PHOSPHATE BINDERS' 461 = '461 TOPICAL ANTI-ROSACEA AGENTS' ;